STADA Arzneimittel Profile

USD 0.000003  0.00%

STADA Arzneimittel Summary

STADA Arzneimittel Aktiengesellschaft (STDAF) is traded on OTC Market in USA. It is located in Stadastrasse 2-18 and employs 11,117 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 6.85 B. STADA Arzneimittel Aktiengesellschaft has 62.26 M outstanding shares. STADA ARZNEIMI NA has accumulated about 493.19 M in cash with 430.52 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.92.
Check STADA Arzneimittel Probability Of Bankruptcy

STADA Arzneimittel A Risk Profiles

Key Fundamentals

STADA Arzneimittel Against Markets

Current Ratings

STADA Arzneimittel 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
< 32% 
Equity ratings for STADA Arzneimittel Aktiengesellschaft are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
STADA Arzneimittel Aktiengesellschaft engages in the development and marketing of pharmaceutical products for the health care and pharmaceutical markets worldwide. STADA Arzneimittel Aktiengesellschaft is a subsidiary of Nidda Healthcare Holding GmbH. STADA Arzneimittel is traded on OTC Market in USA. more
NameSTADA Arzneimittel Aktiengesellschaft
ChairmanMartin AbendView All
Analyst Consensus
Macroaxis Advice
InstrumentUSA Stock View All
Business AddressStadastrasse 2-18
ExchangeOTC Market
Contact Number49 6101 603 0
CurrencyUSD - US Dollar

Did you try this?

Run Technical Analysis Now

Technical Analysis

Check basic technical indicators and analysis based on most latest market data
Hide  View All  NextLaunch Technical Analysis

Diversify with STADA Arzneimittel Aktiengesellschaft

Build Optimal Portfolios
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add STADA Arzneimittel Aktiengesellschaft to your portfolio


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  


STADA Arzneimittel Corporate Management
Carl Oetker Member of the Supervisory Board
JanNicolas Garbe Member of the Supervisory Board
Dieter Koch Member of the Supervisory Board
Eckhard Brueggemann Member of the Supervisory Board, Ph.D